137 related articles for article (PubMed ID: 27518679)
1. Radiation plus Chemotherapy in Low-Grade Glioma.
Knisely J; Schulder M
N Engl J Med; 2016 Aug; 375(5):490. PubMed ID: 27518679
[No Abstract] [Full Text] [Related]
2. Radiation plus Chemotherapy in Low-Grade Glioma.
Touat M; Idbaih A; Sanson M
N Engl J Med; 2016 Aug; 375(5):489-90. PubMed ID: 27518678
[No Abstract] [Full Text] [Related]
3. Radiation plus Chemotherapy in Low-Grade Glioma.
Buckner JC; Chakravarti A; Curran WJ
N Engl J Med; 2016 Aug; 375(5):490-1. PubMed ID: 27518677
[No Abstract] [Full Text] [Related]
4. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ
N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206
[TBL] [Abstract][Full Text] [Related]
5. [Gliomas in adults: primary non-surgical treatment].
Poulsen HS
Ugeskr Laeger; 2006 Nov; 168(47):4082-5. PubMed ID: 17134603
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors in chemotherapy of recurrent brain tumors.
Eagan RT; Scott M
J Clin Oncol; 1983 Jan; 1(1):38-44. PubMed ID: 6321671
[TBL] [Abstract][Full Text] [Related]
7. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD; Scott M
Cancer Treat Rep; 1982 Aug; 66(8):1647-9. PubMed ID: 7105055
[No Abstract] [Full Text] [Related]
8. [Chemo-radiotherapy for malignant brain tumors].
Kochi M; Ushio Y
Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
[TBL] [Abstract][Full Text] [Related]
9. Low-grade oligodendroglioma: current treatments and future hopes.
Lwin Z; Gan HK; Mason WP
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1651-61. PubMed ID: 19895248
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
11. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
12. [Combined treatment of glyal and metastatic tumors of the brain].
Fadeev BP; Zhabina RM
Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
[TBL] [Abstract][Full Text] [Related]
13. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic oligodendroglial tumors: a tale of two trials.
Gilbert MR; Lang FF
J Clin Oncol; 2006 Jun; 24(18):2689-90. PubMed ID: 16782906
[No Abstract] [Full Text] [Related]
15. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres].
Iun'pén V; Oliushin VE; Ulitin AIu; Maslova LN; Petrov AA
Zh Vopr Neirokhir Im N N Burdenko; 2008; (2):6-10; discussion 10-1. PubMed ID: 18720725
[TBL] [Abstract][Full Text] [Related]
16. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
17. [Evolution of chemotherapy for malignant brain tumors].
Takeshima H; Kuratsu J
No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
[No Abstract] [Full Text] [Related]
18. Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients.
Kuratsu JI; Arita N; Kayama T; Kubo N; Mori T; Sawamura Y; Ushio Y
J Neurooncol; 2000 Jun; 48(2):145-9. PubMed ID: 11083079
[TBL] [Abstract][Full Text] [Related]
19. Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.
Mokhtari K; Ducray F; Kros JM; Gorlia T; Idbaih A; Taphoorn M; Wesseling P; Hoang-Xuan K; Van den Bent M; Sanson M
Cancer; 2011 Jul; 117(13):3014-26. PubMed ID: 21246521
[TBL] [Abstract][Full Text] [Related]
20. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
; Cairncross G; Berkey B; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Laperierre N; Mehta M; Curran W
J Clin Oncol; 2006 Jun; 24(18):2707-14. PubMed ID: 16782910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
